The combination of cyclophosphomide, thalidomide and dexamethasone is an effective alternative to cyclophosphamide – vincristine – doxorubicin – methylprednisolone as induction chemotherapy prior to autologous transplantation for multiple myeloma: a case-matched analysis-Reference-Cited by-同舟云学术

The combination of cyclophosphomide, thalidomide and dexamethasone is an effective alternative to cyclophosphamide – vincristine – doxorubicin – methylprednisolone as induction chemotherapy prior to autologous transplantation for multiple myeloma: a case-matched analysis

Published:2006-01 Issue:11 Volume:47 Page:2335-2338
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Wu Ping,Davies Faith E.,Horton Clive,Jenner Matthew W.,Krishnan Biju,Alvares Caroline L.,Saso Radovan,Mccormack Rita,Dines Sharon,Treleaven Jennifer G.,Potter Michael N.,Ethell Mark E.,Morgan Gareth J

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190600821955

Reference21 articles.

1. Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

2. A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma

3. Combination Therapy With Thalidomide Plus Dexamethasone for Newly Diagnosed Myeloma

4. Thalidomide Alone or With Dexamethasone for Previously Untreated Multiple Myeloma

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms Contributing to Acquired Activated Protein C Resistance in Patients Treated with Thalidomide: A Molecular Dynamics Study;Cardiovascular & Hematological Disorders-Drug Targets;2022-12

2. Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial;Haematologica;2020-06-04

3. Analysis of the Efficacy of Thalidomide Plus Dexamethasone-Based Regimens in Patients With Relapsed/Refractory Multiple Myeloma Who Received Prior Chemotherapy, Including Bortezomib and Lenalidomide: KMM-166 Study;Clinical Lymphoma Myeloma and Leukemia;2020-02

4. Mieloma múltiple en Chile: pasado, presente y futuro del programa nacional de drogas antineoplásicas (PANDA). Revisión de 1.103 pacientes;Revista médica de Chile;2018-07

5. Multiple myeloma and persistence of drug resistance in the age of novel drugs (Review);International Journal of Oncology;2016-05-11